Cite
HARVARD Citation
Nakachi, K. et al. (2023). Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 401 (10372), pp. 195-203. [Online].